Akston Biosciences
  • Programs
    • Pipeline
    • Platform
    • Process
  • Company
    • Overview
    • Leadership
    • Facilities
    • Partners
    • Contact
  • Careers
    • Overview
    • Career Opportunities
    • Our Culture
    • Contact
  • News
    • Overview
    • In The News
    • Press Releases
    • Papers

News

In The News

7 September 2022

Akston starts small and likes it that way

5 September 2022

Dechra Pharmaceuticals achieves strong organic growth in all key markets

1 July 2022

Why Indian Pharma Must Evolve As ‘Value Creator’?

See all News

Press Releases

Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA

Akston Biosciences Strengthens Board with Addition of John T. Preston

See all Press

Papers

23 February 2023

A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452

27 May 2022

Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs

See all Papers

Akston BioSciences

info@akstonbio.com |

  • Home
  • Company
  • Pipeline
  • Careers
  • Press Releases
  • Contact

©2023 Akston Biosciences Corporation